Last updated on June 2018

Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan


Brief description of study

For Non-dialysis subjects with anemia associated with chronic kidney disease, demonstrate non-inferiority of MT-6548 compared to darbepoetin alfa using Hb value and evaluate long-term safety of MT-6548.

For subjects not currently receiving ESAs, evaluate Hb correction and maintenance effect of MT-6548 and for subjects currently receiving ESAs, evaluate Hb conversion and maintenance effect of MT-6548

Clinical Study Identifier: NCT03329196

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Information Desk, to ...

Research site
Shiga, Japan
1.22miles
  Connect »

Clinical Trials Information Desk, to ...

Research site
Kyoto, Japan
4.92miles
  Connect »